Andrea E. Bonny, MD

Andrea E. Bonny, MD is a principal investigator in the Center for Clinical and Translation Research at the Research Institute at Nationwide Children’s Hospital and an Assistant Professor of Pediatrics at the Ohio State University. She is also the Director of Research for the Division of Adolescent Medicine at Nationwide Children’s Hospital.

Gender:

• Female

Languages Spoken:

• English
• Spanish

Research Center:

• Center for Clinical and Translational Research

Areas of Interest:

• Adolescence is a critical period of body composition changes including increases in bone mineral density, lean body mass and total body fat. Medications commonly used by adolescents may result in abnormal losses of bone mineral density and/or increases in body fat, increasing an adolescent’s risk of osteopenia or obesity later in life. Our current work examines the mechanisms of weight gain and bone mineral density loss among adolescents who utilize hormonal contraceptive methods. We have been evaluating the peripheral fat cell response to depot medroxyprogesterone acetate and characterizing pharmacokinetic-pharmacodynamic profiles among adolescents on this progestin. Our goal is to help minimize adverse effects related to medications while maintaining efficacy.

Undergraduate

• Notre Dame
  Date Completed: 06/30/1988

Medical School

• Washington University School of Medicine
  Date Completed: 05/31/1994

Internship

• Cincinnati Children's Hospital Medical Center
  Date Completed: 09/19/1997

Graduate School

• University of Cincinnati
  Date Completed: 06/30/2000

Fellowship

• Cincinnati Children's Hospital Medical Center
  Date Completed: 12/31/2000

Department:

• Pediatrics

Section:

• Adolescent Health

Speciality:

• Adolescent Medicine, Certified
  
• Pediatrics, Certified
  

Date of Appointment at Children's Hospital:

• 01/01/2011

• Bonny AE, Secic M, Cromer B. 2011. Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.  Obstet Gynecol. Vol. 117, no. 4. (April): 793-797.
• Bonny AE, Secic M, Cromer B. 2011. Relationship between weight and bone mineral density in adolescents on hormonal contraception.  J Pediatr Adolesc Gynecol. Vol. 24, no. 1. (February): 35-38.
• Bonny AE, Secic M, Cromer BA. Relationship between Weight and Bone Mineral Density in Adolescents on Hormonal Contraception. J Pediatr Adolesc Gynecol 2010; in press.
• Bonny AE, Secic M, Cromer BA. A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception. J Adolesc Health 2009; 45:423-5.
• Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, Camlin-Shingler K, Secic M.  Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.  Fertil Steril 2008; 90:2060-7.
• Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and non-obese adolescent females initiating depot medroxyprogesterone acetate, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006; 160:40-45.
• Cromer BA, Lazebnik R, Rome E, Stager M, Bonny A, Ziegler J, Debanne SM. A double-blinded randomized controlled trial of estrogen supplementation in adolescent girls receiving depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol 2005; 192:42-47.
• Bonny AE, Brouhard B. Urinary Tract Infections among Adolescents. Adolesc Med 2005; 16:149-161.
• Harkness LS, Bonny AE. Calcium and Vitamin D Status in the Adolescent: Key Roles for Bone, Body Weight, Glucose Tolerance, and Estrogen Biosynthesis. J Pediatr Adolesc Gynecol 2005; 18:305-311.
• Bonny AE, Harkness LS, Cromer BA. Depot Medroxyprogesterone Acetate: Implications for Weight Status and Bone Mineral Density in the Adolescent Female. Adolesc Med 2005; 16:569-584.
• Steinemann TL, Fletcher M, Bonny AE, Harvey RA, Hamlin D, Zloty P, Besson M, Walter K, Gagnon M. Over-the-counter decorative contact lenses: cosmetic or medical devices: a case series. Eye Contact Lens 2005; 31:194-200.
• Rome E, Ziegler J, Secic M, Lazebnik R, Bonny A, Stager M, Cromer BA. Bone biochemical markers in adolescent girls on depot medroxyprogesterone acetate (DMPA) and an oral contraceptive containing 20 mcg ethinyl estradiol/100 mcg levonorgestrel. J Pediatr Adolesc Gynecol 2004; 17:373-377
• Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Debanne SM.  Depot medroxyprogesterone acetate, oral contraceptives and BMD in a cohort of adolescent girls. J Adolesc Health 2004; 35:434-441.
• Bonny AE, Britto MT, Huang B, Succop P, Slap GB. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol.2004:109-115.
• Wheeler DS, Bonny AE, Ruddy RM, Jacobs BR. Late-onset respiratory distress after inhalation of laundry detergent. Pediatr Pulmonol  2003; 35:323-325.
• Britto MT, Klostermann BK, Bonny AE, Altum SA, Hornung RW. Impact of school-based intervention on access to health care for underserved youth. J Adolesc Health 2001:29:116-124.
• Bonny AE, Britto MT, Klostermann BK, Hornung RW, Slap GB. School disconnectedness: Identifying adolescents at risk. Pediatrics 2000;106:1017-1021.
• Bonny AE, Biro FM. Recognizing and treating STDs in the adolescent. Contemp Ob/Gyn 1997;42:37-49; also published as: Recognizing and treating STDs in adolescent girls. Contemp Ped 1998;15:119-143; and as: Managing STDs in adolescent girls. Contemp Urol 1998;10:61-77.
• Kao G, Mannix DG, Holaway BL, Finn MC, Bonny AE, Clancy MJ. Dependence of inessential late gene expression on early meiotic events in Saccharomyces cerevisiae. Mol Gen Genet 1989:215:490-500.